Skip to main content
SpringerLink
Log in

Are Outcomes Better for Trauma Patients Who Are Treated Early with Clotting Factors?

  • Chapter
  • First Online:
You’re Wrong, I’m Right

  • 147 Accesses

Abstract

A 72-year-old male with known coronary artery disease presents to his community hospital’s emergency department (ED) with multiple long-bone fractures and a blood pressure of 65/40 following a severe motor vehicle accident. It is also noted that the patient has a widened mediastinum.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63:805–13.

    Article  PubMed  Google Scholar 

  2. Enticott JC, Jeffcott S, Ibrahim JE, Wood EM, Cole-Sincalire M, Fitzgerald M, et al. A review on decision support for massive transfusion: understanding human factors to support the implementation of complex interventions in trauma. Transfusion. 2012;52:2692–705.

    Article  PubMed  Google Scholar 

  3. Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313:471–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, et al. CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23–32.

    Article  CAS  PubMed  Google Scholar 

  5. Ho AM, Dion PW, Yeung JH, Holcomb JB, Critchley LA, Ng CS, et al. Prevalence of survivor bias in observational studies on fresh frozen plasma: erythrocyte ratios in trauma requiring massive transfusion. Anesthesiology. 2012;56:215–6.

    Google Scholar 

  6. Mitra B, O’Reilly G, Cameron PA, Zatta A, Gruen RL. Effectiveness of massive transfusion protocols on mortality in trauma: a systematic review and meta-analysis. ANZ J Surg. 2013;83(12):918–23.

    Article  PubMed  Google Scholar 

  7. Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med. 2010;363(19):1791–800.

    Article  CAS  PubMed  Google Scholar 

  8. Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Crash-2 Collaborators, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011;377(9771):1096–101.

    Article  CAS  PubMed  Google Scholar 

  9. Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, CONTROL Study Group, et al. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma. 2010;69(3):489–500.

    Article  CAS  PubMed  Google Scholar 

  10. Mitra B, Gabbe BJ, Kaukonen KM, Olaussen A, Cooper DJ, Cameron PA. Long-term outcomes of patients receiving a massive transfusion after trauma. Shock. 2014;42(4):307–12.

    Article  PubMed  Google Scholar 

  11. McDaniel LM, Etchill EW, Raval JS, Neal MD. State of the art: massive transfusion. Transfus Med. 2014;24:138–44.

    Article  CAS  PubMed  Google Scholar 

  12. Escolar G, Mazzara R, Castillo R, Ordinas A. The role of the Baumgartner technique in transfusion medicine: research and clinical applications. Transfusion. 1994;34(6):542–9.

    Article  CAS  PubMed  Google Scholar 

  13. Zink KA, Sambasivan CN, Holcomb JB, Chisholm G, Schreiber MA. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg. 2009;197(5):565–70.

    Article  PubMed  Google Scholar 

  14. Pati S, Matijevic N, Doursout MF, Ko T, Cao Y, Deng X, et al. Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw. J Trauma. 2010;69(Suppl 1):S55–63.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Chapman MP, Moore EE, Ramos CR, Ghasabyan A, Harr JN, Chin TL, et al. Fibrinolysis greater than 3 % is the critical value for initiation of antifibrinolytic therapy. J Trauma Acute Care Surg. 2013;75(6):961–7 (discussion 967).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Kutcher ME, Kornblith LZ, Narayan R, Curd V, Daley AT, Redick BJ, et al. A paradigm shift in trauma resuscitation: evaluation of evolving massive transfusion practices. JAMA Surg. 2013;148(9):834–40.

    Article  PubMed  Google Scholar 

  17. Hess JR, Thomas MJG. Blood use in war and disaster: lessons from the past century. Transfusion. 2003;43(11):1622–33.

    Article  CAS  PubMed  Google Scholar 

  18. Tapia NM, Chang A, Norman M, Welsh F, Scott B, Wall MJ Jr, et al. TEG-guided resuscitation is superior to standardized MTP resuscitation in massively transfused penetrating trauma patients. J Trauma Acute Care Surg. 2013;74(2):378–86.

    Article  CAS  PubMed  Google Scholar 

  19. Meng ZH, Wolberg AS, Monroe DM III, Hoffman M. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma. 2003;55(5):886–91.

    Article  CAS  PubMed  Google Scholar 

  20. Vu EN, Schlamp RS, Wand RT, Kleine-Deters GA, Vu MP, Tallon JM. Prehospital use of tranexamic acid for hemorrhagic shock in primary and secondary air medical evacuation. Air Med J. 2013;32(5):289–92.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, The Icahn School of Medicine at Mount Sinai, Manhattan, New York, USA

    Steven D. Boggs

  2. Department of Anesthesiology, James J. Peters VA Medical Center and the Mount Sinai Hospital, 130 West Kingsbridge Road, Bronx, New York, 10468, USA

    Steven D. Boggs

  3. 1133 Midland Avenue, Apt. 3G, Bronxville, New York, 10708-6472, USA

    Steven D. Boggs

  4. Department of Surgery, Cheyenne VA Medical Center, 2360 East Pershing Blvd., Cheyenne, Wyoming, 82001, USA

    Ian H. Black

Authors
  1. Steven D. Boggs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ian H. Black
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven D. Boggs .

Editor information

Editors and Affiliations

  1. Clinical Professor of Anesthesiology, Department of Anesthesiology, Perioperative Care and Pain Medicine, New York University School of Medicine, New York, New York, USA

    Corey S. Scher

  2. Assistant Professor, Department of Anesthesia and Critical Care, The University of Chicago, Chicago, Illinois, USA

    Anna Clebone

  3. Clinical Professor of Anesthesiology (Emeritus), Former Assistant Director of Anesthesiology, Bellevue Hospital Center Retired from Department of Anesthesiology, Bellevue Hospital Center, New York University School of Medicine, New York, New York, USA

    Sanford M. Miller

  4. Clinical Associate Professor of Anesthesiology and Surgery, Bellevue Hospital Center, Department of Anesthesiology, Perioperative Care and Pain Medicine, New York University School of Medicine, Surgical Intensive Care Unit, New York, New York, USA

    J. David Roccaforte

  5. Department of Anesthesiology, Perioperative Care and Pain Medicine, Vice Chair Faculty Promotion Associate Director Anesthesia Service Bellevue Hospital Center, New York, New York, USA

    Levon M. Capan

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Boggs, S.D., Black, I.H. (2017). Are Outcomes Better for Trauma Patients Who Are Treated Early with Clotting Factors?. In: Scher, C., Clebone, A., Miller, S., Roccaforte, J., Capan, L. (eds) You’re Wrong, I’m Right. Springer, Cham. https://doi.org/10.1007/978-3-319-43169-7_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43169-7_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43167-3

  • Online ISBN: 978-3-319-43169-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation